About the conference
The Frankfurt Cancer Conference is a three-day on-site meeting of internationally leading cancer researchers as well as junior scientists and clinical oncologists. The main theme of the conference in 2024 is “Targeting the tumor-host interface”.
The ongoing translational research activities of the University Cancer Center (UCT) Frankfurt, the German Cancer Consortium (DKTK) in Frankfurt/Mainz and the Frankfurt Cancer Institute (FCI) provide the framework for the conference. International, national and local research activities will be presented with focus on the following topics:
- Metabolism at the tumor-host interface
- Targeted cell therapy
- Molecular drug discovery
- Modulating immune therapy response
- Post-transcriptional disease mechanisms
- Exploitation of the tumor microenvironment
Target audience
The conference targets basic and translational researchers as well as oncologists who are interested in cancer biology, novel cancer therapies and mechanism-based clinical trials. We want to encourage both early-career cancer researchers as well as clinical oncologists to participate and present their work to the international community. There will be plenty of opportunities to interact with experts in the field of cancer research and to establish or deepen collaborations in an inspiring atmosphere.
Scientific Organizing Committee
Prof. Dr. Hubert Serve
Chair of Scientific Organizing Committee
Department of Medicine 2, Hematology/Oncology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK) and DKFZ
Prof. Dr. Thomas Oellerich
Co-Chair of Scientific Organizing Committee
Department of Medicine 2, Hematology/Oncology
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
University Cancer Center (UCT) Frankfurt
Prof. Dr. Melek Canan Arkan
Georg-Speyer-Haus
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Peter Bader
Department of Pediatrics
University Cancer Center (UCT) Frankfurt
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Halvard B. Bönig
Department for Cellular Therapeutics / Cell Processing (GMP)
German Red Cross Blood Service Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Christian Brandts
Department of Medicine 2, Hematology/Oncology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Christian Buchholz
Paul-Ehrlich-Institut (PEI)
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
PD Dr. med. Gesine Bug
Department of Medicine 2, Hematology/Oncology
University Cancer Center (UCT) Frankfurt
Goethe University Frankfurt
Prof. Dr. Florian Büttner
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Dr. Anjali Cremer
Department of Medicine 2, Hematology/Oncology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Dr. Anne Fassl
Department of Urology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Prof. Dr. Fabian Finkelmeier
Department of Medicine 1, Gastroenterology/Pneumology/Endocrinology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Dr. Nicola Gökbuget
Department of Medicine 2, Hematology/Oncology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Florian Greten
Georg-Speyer-Haus
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Dr. Ann-Christin Hau
Institute for Neurology (Edinger Institute)
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Dr. Katharina Imkeller
Institute for Neurology (Edinger Institute)
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Jan-Henning Klusmann
Department of Pediatrics
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Stefan Knapp
Institute for Pharmaceutical Chemistry
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Dr. Konstantinos Kokkaliaris
Dr. Senckenberg Institute of Pathology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Dr. Susanne Müller-Knapp
Institute for Pharmaceutical Chemistry
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Prof. Dr. Karlheinz Plate
Institute for Neurology (Edinger Institute)
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Dr. Yvonne Reiss
Institute for Neurology (Edinger Institute)
University Cancer Center (UCT) Frankfurt
Goethe University Frankfurt
German Cancer Consortium (DKTK)
PD Dr. Eva Rettinger
Department of Pediatrics
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Michael Rieger
Department of Medicine 2, Hematology/Oncology
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK) and DKFZ
Prof. Dr. Claus Rödel
Department of Radiation Therapy and Oncology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Joachim Steinbach
Dr. Senckenberg Institute of Neurooncology
University Cancer Cancer (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Dr. Hannah Uckelmann
Department of Pediatrics
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Prof. Dr. Evelyn Ullrich
Department of Pediatrics
University Cancer Cancer (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
German Cancer Consortium (DKTK)
Prof. Dr. Janne Vehreschild
Department of Medicine 2, Hematology/Oncology
Frankfurt Cancer Institute (FCI)
University Cancer Cancer (UCT) Frankfurt
Goethe University Frankfurt
German Cancer Consortium (DKTK)
PD Dr. Pia Zeiner
Dr. Senckenberg Institute of Neurooncology
University Cancer Cancer (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK)
Confirmed Speakers
Iannis Aifantis
Chair, Department of Pathology
NYU Grossman School of Medicine
New York, US
Jay Bradner
Harvard Medical School
Boston, US
Alessio Ciulli
Professor of Chemical and Structural Biology
University of Dundee
Dundee, Scotland, UK
Eran Elinav
Department of Systems Immunology
Weizmann Institute of Science
Rehovot, IL
Sarah-Maria Fendt
VIB KU Leuven Center for Cancer Biology
Leuven, BE
Lydia Finley
Geoffrey Beene Junior Faculty Chair
Memorial Sloan Kettering Cancer Center
New York, US
Michaela Frye
German Cancer Research Center (DKFZ)
Heidelberg, DE
Stephen Gottschalk
Chair, Department of Bone Transplant and Cellular Therapy
St. Jude Children’s Research Hospital
Memphis, US
Florian Greten
Georg-Speyer-Haus Institute for Tumor Biology and Experimental Therapy
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Frankfurt, DE
Michael Kharas
Memorial Sloan Kettering Cancer Center
New York, US
Thomas Oellerich
Department of Medicine 2, Hematology/Oncology,
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Frankfurt, DE
Stefan Knapp
Institute for Pharmaceutical Chemistry
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Frankfurt, DE
Ravi Majeti
Director, Stanford Institute for Stemm Cell Biology and Regenerative Medicine
Stanford, US
Christian Reinhardt
Department of Hematology and Stem Cell Transplantation
University Hospital Essen
Essen, DE
Rizwan Romee
Principal Investigator
Dana-Farber Cancer Institute
Boston, US
Marco Ruella
Center for Cellular Immunotherapies
University of Pennsylvania
Philadelphia, US
Hubert Serve
Department of Medicine 2, Hematology/Oncology
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Frankfurt, DE
Evelyn Ullrich
Department of Pediatrics
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
Frankfurt, DE
Marcel R. M. van den Brink
Memorial Sloan Kettering Cancer Center
New York, US
Georg E. Winter
Center for Molecular Medicine
Medical University Vienna
Vienna, AT
Program
The preliminary program of the Frankfurt Cancer Conference 2024 will be published here soon.
Registration
The online registration for the Frankfurt Cancer Conference 2024 will open in January 2024.
Abstract Submission
The online abstract submission for the Frankfurt Cancer Conference 2024 will open in January 2024.
The deadline for abstract submission will be March 30, 2024.
Address of on-site venue
Goethe University Frankfurt
Westend Campus
Theodor-W.-Adorno-Platz 1
60323 Frankfurt am Main
Casino building
Festsaal I (Room 823)
accessible by foot via Nina-Rubinstein-Weg
Contact
Chairs of the Scientific Organizing Committee
Prof. Dr. Hubert Serve
Department of Medicine 2, Hematology/Oncology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK) and DKFZ
Prof. Dr. Thomas Oellerich
Department of Medicine 2, Hematology/Oncology
University Cancer Center (UCT) Frankfurt
Frankfurt Cancer Institute (FCI)
Goethe University Frankfurt
German Cancer Consortium (DKTK) and DKFZ
Conference Managers
Dr. Angelika Oellerich
a.oellerich@med.uni-frankfurt.de
Tel: +49 (0)69 / 6301-5459
Birgit Rosiejak
rosiejak@em.uni-frankfurt.de
Tel: +49 (0)69 / 6301-5459
Press Relations
Felicitas Cremer
felicitas.cremer@med.uni-frankfurt.de
Tel: +49 (0)69 / 6301-87335